Asymptomatic hyperthyroidism in older adults: Is it a distinct clinical and laboratory entity?

Drugs and Aging

Volumn 25, Issue 5, 2008, Pages 371-380

  Mooradian, Arshag D ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Elderly; Hyperthyroidism, diagnosis; Levothyroxine sodium, therapeutic use

Indexed keywords

ALPHA INTERFERON; ALUMINUM HYDROXIDE; AMIODARONE; ANABOLIC AGENT; CARBAMAZEPINE; COLESTIPOL; COLESTYRAMINE; CORTICOSTEROID; DIAMORPHINE; DOPAMINE; ESTROGEN; FERROUS SULFATE; FLUOROURACIL; INTERLEUKIN 2; IODIDE; LEVOTHYROXINE; LIOTHYRONINE; LITHIUM; METHADONE; NICOTINIC ACID; OCTREOTIDE; PHENOBARBITAL; PHENYTOIN; PROTIRELIN; RADIOACTIVE IODINE; RIFAMPICIN; TAMOXIFEN; THYROID HORMONE; THYROTROPIN; UNINDEXED DRUG;

AGED; AGING; APATHY; ASYMPTOMATIC HYPERTHYROIDISM; CASE REPORT; CLINICAL EVALUATION; DRUG ABSORPTION; FEMALE; GENE EXPRESSION REGULATION; HEART ARRHYTHMIA; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LABORATORY TEST; LIVER METABOLISM; ONSET AGE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SYMPTOMATOLOGY; SYNDROME; THYROID HORMONE RELEASE; THYROID HORMONE RESISTANCE; THYROTROPIN RELEASE; WEIGHT REDUCTION;

AGED; AGING; ANTITHYROID AGENTS; FEMALE; HUMANS; HYPERTHYROIDISM; THYROID HORMONES;

EID: 43049135165     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200825050-00002     Document Type: Review

References (40)

1. Oiknine RF, Mooradian AD. Thyroid disorders. In: Pathy MS, Sinclair AJ, Morley JE, editors. Principles and practice of geriatric medicine. Vol. 2. 4th ed. Chichester: John Wiley and Sons Limited, 2006: 1405-14
2. Helfand M. Screening for subclinical thyroid dysfunction in non-pregnant adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2004; 140: 128-41
3. Toft A. Subclinical hyperthyroidism. N Engl J Med 2001; 345: 512-6
4. Diez JJ. Hyperthyroidism in patients older than 55 years: an analysis of the etiology and management. Gerontology 2003; 49: 316-23
5. Samuels MH. Subclinical thyroid disease in the elderly. Thyroid 1998; 8: 803-13
6. Case CC, Mooradian AD. Thyroid changes with aging. In: Morley JE, Armbrecht HJ, Coe RM, et al., editors. The science of geriatrics: facts. Research and intervention in geriatrics series. Vol. 1. Paris: Serdi Publisher, 2000: 273-81
7. Mooradian AD, Wong NC. Age-related changes in thyroid hormone action. Eur J Endocrinol 1994; 131: 451-61
8. Shah GN, Li JP, Schneiderjohn P, et al. Cloning and characterization of a complementary DNA for a thyroid hormone responsive protein in mature rat cerebral tissue. Biochem J 1997; 327: 617-23
9. Shah GN, Li J, Mooradian AD. Novel translational repressor (NAT-1) expression is modified by thyroid state and age in brain and liver. Eur J Endocrinol 1999; 139: 649-53
10. Mooradian AD, Li J, Shah GN. Age-related changes in thyroid hormone responsiveness protein (THRP) expression in cerebral tissue of rats. Brain Res 1998; 793: 302-4
11. Mooradian AD, Scarpace PJ. 3,5,3′-L-triiodothyronine regulation of B-adrenergic receptor density and adenylyl cyclase activity in synaptosomal membranes of aged rats. Neurosci Lett 1993; 161: 101-4
12. Mooradian AD, Scarpace PJ. The response of isoproterenol-stimulated adenylate cyclase activity after administration of L-triiodothyronine is reduced in aged rats. Horm Metab Res 1989; 21: 638-9
13. Mooradian AD. Blood-brain transport of triiodothyronine is reduced in aged rats. Mech Ageing Dev 1990; 52: 141-7
14. Mooradian AD. The hepatic transcellular transport of 3, 5, 3′-triiodothyronine is reduced in aged rats. Biochim Biophys Acta 1990; 1054: 1-7
15. 14 gene expression in response to thyroid hormone and age. Proc Soc Exp Biol Med 1994; 207: 97-101
16. Mariotti S, Franceschi C, Cosarizza A, et al. The aging thyroid. Endocr Rev 1995; 16: 686-715
17. Trivalle C, Doucet J, Chassagne P, et al. Differences in the signs and symptoms of hyperthyroidism in older and younger patients. J Am Geriatr Soc 1996; 44: 50-3
18. Hershman JM, Pekary AE, Berg L, et al. Serum thyrotropin and thyroid hormone levels in elderly and middle-aged euthyroid persons. J Am Geriatr Soc 1993; 41: 823-8
19. Van Coevorden A, Laurent E, Decoster C, et al. Decreased basal and stimulated thyrotropin secretion in healthy elderly men. J Clin Endocrinol Metab 1989; 69: 177-85
20. Friedman D, Reed RL, Mooradian AD. The prevalence of over medication with levothyroxine in ambulatory elderly patients. Age 1992; 15: 9-13
21. Ordene KW, Pan C, Barzel US, et al. Variable thyrotropin response to thyrotropin-releasing hormone after small decreases in plasma thyroid hormone concentrations in patients of advanced age. Metabolism 1983; 32: 881-8
22. Mooradian AD. Normal age-related changes in thyroid hormone economy. Clin Geriatr Med 1995; 11: 159-69
23. Donda A. Lemarchand-Beraud T. Aging alters the activity of 5′-deiodinase in the adenohypophysis, thyroid gland, and liver of the male rat. Endocrinology 1989; 124: 1305-9
24. Donda A. Reymond MJ. Zurich MG, et al. Influence of sex and age on T3 receptors and T3 concentration in the pituitary gland of the rat: consequences on TSH secretion. Mol Cell Endocrinol 1987; 54: 29-34
25. Sundbeck G, Eden S, Jagenburg R, et al. Thyroid dysfunction in 85-year-old men and women: influence of non-thyroidal illness and drug treatment. Acta Endocrinologica 1991; 125: 475-86
26. Thomas FB, Mazzaferri EL, Skillman TG. Apathetic thyrotoxicosis: a distinctive clinical and laboratory entity. Ann Intern Med 1970; 72: 679-85
27. Beck-Peccoz P, Mannavola D, Persani L. Syndromes of thyroid hormone resistance. Ann Endocrinol (Paris) 2005; 66: 264-9
28. Chatterjee VK. Resistance to thyroid hormone. Horm Res 1997; 48 Suppl. 4: 43-6
29. Beck-Peccoz P, Chatterjee VK. The variable clinical phenotype in thyroid hormone resistance syndrome. Thyroid 1994; 4: 225-32
30. American Association of Clinical Endocrinologists Thyroid Task Force. Medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 2002; 8: 457-67
31. Ladenson PW, Singer PA, Ain KB, et al. American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med 2000; 160: 1573-5
32. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid dis-ease: scientific review and guidelines for diagnosis and management. JAMA 2004; 291: 228-38
33. U.S. Preventive Services Task Force. Screening for thyroid disease: recommendation statement. Ann Intern Med 2004; 140: 125-7 3
34. Biondi B, Palmieri EA, Lombardi G, et al. Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med 2002; 137: 904-14
35. Foldes J, Tarjan G, Szathmari M, et al. BMD in patients with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis? Clin Endocrinol 1993; 39: 521-7
36. Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994; 331: 1249-52
37. Cooper DS, Goldminz D, Levin AA, et al. Agranulocytosis associated with antithyroid drugs: effects of patient age and drug dose. Ann Intern Med 1983; 98: 26-9
38. Surks MI, Sievert R. Drugs and thyroid function. N Engl J Med 1995; 333: 1688-94
39. Mooradian AD, Korenman SG. Endocrinology. In: Braunwald E, editor. Atlas of internal medicine. 3rd ed. Philadelphia (PA): Springer, 2007: 121-79
40. Clinical guidelines part 1: screening for thyroid disease. American College of Physicians. Ann Intern Med 1998; 129: 141-3